Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP
- Recalling company
- Preferred Pharmaceuticals, Inc.
- Product
- Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
- Reason
- Failed Content Uniformity Specifications
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Sep 28, 2026
- Reported
- Oct 14, 2026
- Distribution
- USA Nationwide
- Status
- Ongoing
- Quantity
- N/A
- Lot / codes
- Lot #: F1925G, Expiry: 4/30/2027; Lot #: E0925T, Expiry: 4/30/2027; Lot # D3025M, Expiry: 4/30/2027; Lot #: D0825D, Expiry: 4/30/2027.
- Company location
- Anaheim, CA
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0013-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0013-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.